Report cover image

Global CyberKnife Market Size - By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jun 26, 2025
Length 232 Pages
SKU # SPER20265978

Description

CyberKnife Market Introduction and Overview

According to SPER market research, ‘Global CyberKnife Market Size- By Application, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global CyberKnife Market is predicted to reach 3307.32 million by 2034 with a CAGR of 17.85%.

CyberKnife is a non-invasive robotic radiosurgery tool used to precisely treat cancer and other medical conditions. Unlike traditional surgery, CyberKnife removes tumors, both cancerous and non-cancerous, without the need for incisions or anesthesia. By employing robotic arms and real-time imaging to track and compensate for tumor or patient movement during therapy, it guarantees sub-millimeter accuracy.

Restraints:Despite its clinical merits, the CyberKnife market is not without its restrictions. The cost of setting up and maintaining CyberKnife systems is one of the key challenges, particularly for small and mid-sized healthcare institutions. Its deployment in low-income communities is further limited by the need for skilled workers and specialized infrastructure. Furthermore, lengthy approval processes for innovative technology and regulatory barriers may cause producers to delay their market entry.

Scope of the report:
Report Metric Details Market size available for years 2021-2034 Base year considered 2024 Forecast period 2025-2034

Segments covered
By Application, By End User

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Accuray Incorporated, Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc, Ayasdi AI LLC, Baidu, Inc, Elekta AB, GE Healthcare, IBA Group.

Global CyberKnife Market Segmentation:

By Application:
Based on the Application, Global CyberKnife Market is segmented as; Tumor, Cancer, Vascular Malformation, Others.

By End User:Based on the End User, Global CyberKnife Market is segmented as; Hospitals, Outpatient Facilities, Research & Manufacturing.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

232 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4.Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global CyberKnife Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global CyberKnife Market
7. Global CyberKnife Market, By Application (USD Million) 2021-2034
7.1. Tumor
7.2. Cancer
7.3. Vascular Malformation
7.4. Others
8. Global CyberKnife Market, By End User (USD Million) 2021-2034
8.1. Hospitals
8.2. Outpatient Facilities
8.3. Research & Manufacturing
9. Global CyberKnife Market, (USD Million) 2021-2034
9.1. Global CyberKnife Market Size and Market Share
10. Global CyberKnife Market, By Region, (USD Million) 2021-2034
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5 .Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. Accuray Incorporated
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Advanced Micro Devices
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. AiCure
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Arm Limited
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Atomwise, Inc
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Ayasdi AI LLC
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Baidu, Inc
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Elekta AB
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. GE Healthcare
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. IBA Group
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.